CAS No. |
1296818-77-3 |
|---|---|
英文名称 |
- |
别名 |
Nesvacumab;Research Grade Nesvacumab(DHA42303);Research Grade Nesvacumab;Nesvacumab (anti-ANGPT2) |
用途 |
Nesvacumab is an investigational monoclonal antibody initially developed for the treatment of cancer by targeting angiopoietin-2 (ANGPT2); as of May 2017, it was in Phase II clinical trials for the treatment of diabetic macular edema. |
|
|
评论 |
|---|